BD introduces BD FACSCelesta™ Flow Cytometer During the BD HorizonsTM Global Tour 2016
State-of-the-Art Research System Optimized for Use with BD Horizon Brilliant™ Dyes Is Now Available in India
BD (Becton, Dickinson and Company), a leading global medical technology company, introduced the BD FACSCelesta™flow cytometer during the BD HorizonsTM Global Tour 2016. Uniquely designed to leverage the broad BD Horizon Brilliant™reagent portfolio, this new system offers simultaneous measurement of up to 14 different single cell characteristics.
The BD FACSCelesta isan advanced system for driving scientific insights for a wide range of applications. Available now for research segment use, the BD FACSCelestais the latest advancement in the award winning BD cell analyzer portfolio. It offers performance that is typically only seen in higher end systems, enabling consistency of results and seamless transfer of applications between BD platforms with 14 parameters in a three-laser benchtop system.
For more significant single cell studies and higher quality data, the BD FACSCelesta system opens new avenues of investigation and a deeper level of biological study. When combined with the patented technology of BD Horizon Brilliant™ polymer dyes, it enables greater resolution of previously unobserved cell populations and is an ideal solution for researchers wanting more
fluorophore choices when using multicolor flow cytometry.“Designed from the ground up, the BD FACSCelesta allows researchers to benefit from new innovations in instrument and reagent technology,” said Claude Dartiguelongue, worldwide president of BD Biosciences.“This means that researchers can now,with improved brightness and low spectral overlap, optimally identify, characterize, and resolve even dim staining populations of interest.”
The BD FACSCelesta flow cytometer is available in multiple configurations, delivering the performance required for varied immunology and cell biology applications. The system can help simplify experimental design and analysis for experienced researchers as well as those new to flow cytometry. The four configurations allow the use of 10 or 12 colors.
About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance cellular studies and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit www.bd.com.
